Is BIO or HSIC cheaper?

On trailing earnings, HSIC is cheaper: BIO trades at a 46.31 P/E and HSIC at 23.77.

Which has grown faster, BIO or HSIC?

Over the past five years, HSIC grew revenue faster — BIO at a -0.84% CAGR versus HSIC at 4.74%.

Is BIO or HSIC more profitable?

BIO runs the higher net margin — BIO at 6.52% versus HSIC at 2.95%.

Which has been the better investment, BIO or HSIC?

Over the past 10-year, BIO delivered the higher annualized total return — BIO at 7.08% versus HSIC at 1.38%. Past performance doesn't predict future results.

Bio-Rad Laboratories, Inc. (BIO) vs Henry Schein, Inc. (HSIC)

HSIC leads on 10 of 14 compared metrics.

A side-by-side comparison of Bio-Rad Laboratories, Inc. and Henry Schein, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 23, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

BIO

Bio-Rad Laboratories, Inc.

Total return — BIO vs HSIC

growth of $100 · last 30y

BIO +1572.0%HSIC +1046.3%BIO compounded faster

BIO HSIC

BIO vs HSIC: by the numbers

•HSIC is the larger company ($8.96B vs $7.60B market cap).
•HSIC trades at the lower earnings multiple (23.77 vs 46.31 P/E).
•BIO converts more revenue to profit (6.52% vs 2.95% net margin).
•HSIC grew revenue faster over the past five years (4.74% vs -0.84% CAGR).

Which is better, BIO or HSIC?

Metric tally: BIO 4 · HSIC 10

It depends on what you're optimizing for:

ValueHSIC(lower P/E)

GrowthHSIC(faster 5Y revenue CAGR)

QualityHSIC(higher ROIC)

Metrics side by side

Valuation

Metric	BIO	HSIC
P/E ratio	46.31	23.77●
Forward P/E	28.21	14.71●
P/S ratio	2.93	0.68●
P/B ratio	1.11●	2.80
PEG ratio	—	3.23
EV / EBITDA	17.99	12.72●
FCF yield	4.71%	4.72%

Profitability

Metric	BIO	HSIC
Gross margin	51.87%●	29.69%
Operating margin	9.25%●	5.60%
Net margin	6.52%●	2.95%
ROE	2.46%	12.09%●
ROIC	2.04%	6.58%●

Growth (annualized)

Metric	BIO	HSIC
Revenue CAGR (5Y)	-0.84%	4.74%●
EPS CAGR (5Y)	-26.27%	-0.74%●
FCF CAGR (5Y)	-7.57%	-4.53%●
Total return CAGR (5Y)	-14.77%	0.58%●

Frequently asked

Which is better, BIO or HSIC?: It depends on your goal. value: HSIC (lower P/E); growth: HSIC (faster 5Y revenue CAGR); quality: HSIC (higher ROIC). Across all compared metrics, HSIC leads 10 to 4.
Is BIO or HSIC cheaper?: On trailing earnings, HSIC is cheaper: BIO trades at a 46.31 P/E and HSIC at 23.77.
Which has grown faster, BIO or HSIC?: Over the past five years, HSIC grew revenue faster — BIO at a -0.84% CAGR versus HSIC at 4.74%.
Is BIO or HSIC more profitable?: BIO runs the higher net margin — BIO at 6.52% versus HSIC at 2.95%.
Which has been the better investment, BIO or HSIC?: Over the past 10-year, BIO delivered the higher annualized total return — BIO at 7.08% versus HSIC at 1.38%. Past performance doesn't predict future results.

Go deeper

Full BIO analysis Full HSIC analysis Interactive comparison tool

Dig into the metrics

Bio-Rad Laboratories P/E ratio Henry Schein P/E ratio Bio-Rad Laboratories dividend yield Henry Schein dividend yield Bio-Rad Laboratories ROE Henry Schein ROE Bio-Rad Laboratories operating margin Henry Schein operating margin Bio-Rad Laboratories revenue growth Henry Schein revenue growth Bio-Rad Laboratories free cash flow Henry Schein free cash flow

Bio-Rad Laboratories & Henry Schein appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 23, 2026.